Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica

被引:2
作者
Baert, Laurie [1 ]
Marignier, Romain [2 ]
Lassmann, Hans P. [3 ]
Huard, Bertrand [1 ]
机构
[1] Univ Grenoble Alpes, Inst Adv Biosci, Grenoble, France
[2] P Wertheimer Neurol Hosp, MIRCEM, Lyon, France
[3] Med Univ, Ctr Brain Res, Vienna, Austria
来源
FRONTIERS IN NEUROLOGY | 2021年 / 12卷
关键词
neuromyelitis optica; TACI; astrocytes; B cells; APRIL (TNFSF13); SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; ATACICEPT; APRIL; BAFF;
D O I
10.3389/fneur.2021.721877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A proliferation inducing ligand (APRIL) mediates a key role in the generation and survival of antibody-inducing plasmocytes. Based on this, APRIL has been targeted in autoimmune diseases including multiple sclerosis (MS) and optic neuritis (ON). In MS lesions, APRIL has a new cellular target, the reactive astrocyte and mediates an immunosuppressive activity. Here, we analyzed APRIL expression in a case of neuromyelitis optica (NMO), another autoimmune neurodegenerative disease, showing selective aquaporin-4 depletion in the spinal cord, complement deposition and infiltration of polymorphonuclear cells. We analyzed by immunohistochemistry the presence of APRIL-producing cells, plasmocytes, astrocytes and the localization of secreted APRIL in a lesion from NMO. Plasmocytes were present close to APRIL-producing cells in meninges. However, our main observation was that APRIL targets reactive astrocytes in this lesion of NMO similarly to MS.
引用
收藏
页数:4
相关论文
共 11 条
[1]   A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis [J].
Baert, Laurie ;
Benkhoucha, Mahdia ;
Popa, Natalia ;
Ahmed, Mashal C. ;
Manfroi, Benoit ;
Boutonnat, Jean ;
Sturm, Nathalie ;
Raguenez, Gilda ;
Tessier, Marine ;
Casez, Olivier ;
Marignier, Romain ;
Ahmadi, Mitra ;
Broisat, Alexis ;
Ghezzi, Catherine ;
Rivat, Cyril ;
Sonrier, Corinne ;
Hahne, Michael ;
Baeten, Dominique ;
Vives, Romain R. ;
Lortat-Jacob, Hugues ;
Marche, Patrice N. ;
Schneider, Pascal ;
Lassmann, Hans P. ;
Boucraut, Jose ;
Lalive, Patrice H. ;
Huard, Bertrand .
ANNALS OF NEUROLOGY, 2019, 85 (03) :406-420
[2]   Telitacicept Following Plasma Exchange in the Treatment of Subjects With Recurrent NMOSD: Study Protocol for a Single-Center, Single-Arm, Open-Label Study [J].
Ding, Jie ;
Cai, Yu ;
Deng, Ye ;
Jiang, Xianguo ;
Gao, Meichun ;
Lin, Yan ;
Zhao, Nan ;
Wang, Ze ;
Yu, Haojun ;
Lv, Wenwen ;
Zhang, Ying ;
Hao, Yong ;
Guan, Yangtai .
FRONTIERS IN NEUROLOGY, 2021, 12
[3]   Targeting B cells in treatment of autoimmunity [J].
Franks, S. Elizabeth ;
Getahun, Andrew ;
Hogarth, P. Mark ;
Cambier, John C. .
CURRENT OPINION IN IMMUNOLOGY, 2016, 43 :39-45
[4]   Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial [J].
Kappos, Ludwig ;
Hartung, Hans-Peter ;
Freedman, Mark S. ;
Boyko, Alexey ;
Radue, Ernst Wilhelm ;
Mikol, Daniel D. ;
Lamarine, Marc ;
Hyvert, Yann ;
Freudensprung, Ulrich ;
Plitz, Thomas ;
van Beek, Johan .
LANCET NEUROLOGY, 2014, 13 (04) :353-363
[5]   Neurodegeneration in multiple sclerosis and neuromyelitis optica [J].
Kawachi, Izumi ;
Lassmann, Hans .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (02) :137-145
[6]   BAFF and APRIL: A tutorial on B cell survival [J].
Mackay, F ;
Schneider, P ;
Rennert, P ;
Browning, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :231-264
[7]   Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study [J].
Merrill, Joan T. ;
Wallace, Daniel J. ;
Wax, Stephen ;
Kao, Amy ;
Fraser, Patricia A. ;
Chang, Peter ;
Isenberg, David .
ARTHRITIS & RHEUMATOLOGY, 2018, 70 (02) :266-276
[8]   Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica [J].
Misu, Tatsuro ;
Hoeftberger, Romana ;
Fujihara, Kazuo ;
Wimmer, Isabella ;
Takai, Yoshiki ;
Nishiyama, Shuhei ;
Nakashima, Ichiro ;
Konno, Hidehiko ;
Bradl, Monika ;
Garzuly, Ferenc ;
Itoyama, Yasuto ;
Aoki, Masashi ;
Lassmann, Hans .
ACTA NEUROPATHOLOGICA, 2013, 125 (06) :815-827
[9]   Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases [J].
Samy, Eileen ;
Wax, Stephen ;
Huard, Bertrand ;
Hess, Henry ;
Schneider, Pascal .
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2017, 36 (01) :3-19
[10]   Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness [J].
Schwaller, Juerg ;
Schneider, Pascal ;
Mhawech-Fauceglia, Paulette ;
McKee, Thomas ;
Myit, Samir ;
Matthes, Thomas ;
Tschopp, Jurg ;
Donze, Olivier ;
Le Gal, Frederique-Anne ;
Huard, Bertrand .
BLOOD, 2007, 109 (01) :331-338